Single answer

Is Assertio Holdings Inc (ASRT) a buy or sell?

4starter turns market data into one clear verdict you can act on.

Hold
$12.04
+0.190 (+1.60%)
Quote updated: 2026-02-26 15:11 UTC
Trend today
+1.60%
Up today
Volume vs avg
92.72%
0.07x under average
Target gap
80.23%
below current price
Signal updated
Not available
Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers Specialty Generic
Add to watchlist

Create a free account to save tickers and track your signals.

Log in to turn on watchlist alerts.

Decision snapshot

Everything you need to act fast, in one glance.

4starter signal
Hold
Not available

Powered by momentum, volatility, and trend inputs.

Analyst target gap
80.23%
$9.66 below current price

Consensus target $2.38.

Volume vs average
92.72%
under average

3,442 vs 47,301 average (0.07x normal).

What is the conclusion?

Right now our advanced algorithms say:

YES

Do analysts agree?

We compare consensus targets with today's price.

NO

Consensus target for Assertio Holdings Inc is $2.38, which is $9.66 (80.23%) below the current price today's price.

Low target: $1.750 | High target: $3.00

Company snapshot

A quick overview of the business and its public profile.

Assertio Holdings Inc a specialty pharmaceutical company provides medicines in the areas of neurology hospital and pain and inflammation Its pharmaceutical products include INDOCIN an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis including acute flares of chronic disease ankylosing spondylitis and osteoarthritis and acute painful shoulder and gouty arthritis It also provides CAMBIA a nonsteroidal antiinflammatory drug NSAID for the treatment of migraine nausea photophobia and phonophobia Zipsor a NSAID for relief of mild to moderate acute pain SPRIX a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level and Otrexup a singledose autoinjector containing a prescription medicine and methotrexate that is used to treat adults with severe active rheumatoid arthritis and children with active polyarticular juvenile idiopathic arthritis The company was formerly known as Assertio Therapeutics Inc and changed its name to Assertio Holdings Inc in May 2020 Assertio Holdings Inc was incorporated in 1995 and is headquartered in Lake Forest Illinois

Website: https://www.assertiotx.com

Rates and inflation backdrop

US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.

Inflation sensitivity

Debt ratio: 0.12. Cash flow to debt ratio: 0.34. Net profit margin: -21.06%. Inflation risk score: high (0.70/1).

Dividend history check

We cannot find any recorded dividends paid in our systems.

Trading liquidity

No, the average daily trading liquidity for Assertio Holdings Inc is $460,729. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

10-year return check

On Assertio Holdings Inc, 2016-02-26 had a stock price of $65.40. If you invested back then, your return now would be a loss of $53.55 per share or 81.88%.

Why this answer

We combine price momentum, volatility, and trend signals to simplify the decision to one word.

1

Signal engine scans price, trend, and momentum indicators.

2

Targets and sentiment are checked against the live quote.

3

We keep the output simple: buy, sell, or hold.

Analyst consensus

How Wall Street targets compare to today's price.

$2.38
$9.66 (80.23%) below the current price
Range: $1.750 - $3.00

FAQ

Today's 4starter signal is Hold. That means the signal is mixed right now.

Quotes and targets refresh throughout the trading day, with the latest timestamp shown on the page.

It blends momentum, trend, and volatility indicators into a single decision-oriented verdict.